AstraZeneca to invest $50 million in clinical research in Abu Dhabi together with Cleveland Clinic
AstraZeneca and Cleveland Clinic Abu Dhabi are launching a long-term partnership: about 30 clinical studies on cardiovascular, kidney and metabolic diseases. The first six studies have already passed feasibility assessment, with the start due before the end of the year. A collaboration with Oracle on hypertension using AI has also been announced.
Otabek Yusupov